These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8534054)

  • 1. Experts recommend longer treatment for hepatitis C virus.
    Roper CR; Ford D
    AORN J; 1995 Sep; 62(3):358. PubMed ID: 8534054
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long term/intermittent treatment of chronic hepatitis C with recombinant interferon alfa-2b].
    Hakozaki Y; Fujioka T; Katou M; Kondo T; Oba K; Nakagawa K; Shirahama T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1001-6. PubMed ID: 7563656
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interferon treatment for chronic hepatitis C--assessment of 3 regimens in patients received more than 500 MU interferon treatment and their effect predictive factors for interferon treatment using multivariate analysis with the logistic regression model].
    Terada M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1007-11. PubMed ID: 7563657
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of breakthrough in chronic hepatitis C patients undergoing antiviral therapy: role of type and schedule of alpha interferon C.H.S.G.
    Bellati G; Colloredo G; Roffi L; D'Aquino M; Bonino F; Idéo G
    J Hepatol; 1997 Feb; 26(2):449-50. PubMed ID: 9059974
    [No Abstract]   [Full Text] [Related]  

  • 5. [How should hepatitis C be treated? Treatment of hepatitis C with interferon].
    Marcellin P
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S81-8. PubMed ID: 9161518
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of interferon re-therapy and its adaptation in chronic hepatitis C].
    Matsuo S; Ohnishi K; Fujiwara K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1012-6. PubMed ID: 7563658
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen.
    Koff RS
    Am J Gastroenterol; 1996 Oct; 91(10):2072-4. PubMed ID: 8855723
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of interferon alpha in acute hepatitis C in patients on chronic hemodialysis.
    Süleymanlar I; Sezer T; Işitan F; Yakupoglu G; Süleymanlar G
    Nephron; 1998; 79(3):353-4. PubMed ID: 9678442
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current knowledge in the treatment of chronic hepatitis C].
    Pirotte J
    Rev Med Liege; 1995 Dec; 50(12):501-4. PubMed ID: 8570988
    [No Abstract]   [Full Text] [Related]  

  • 10. [Two cases of acute exacerbation of chronic hepatitis C improved after the administration of an immunosuppressive drug and interferon].
    Ikeda H; Nishina K; Asatani Y; Yumoto E; Okano N; Seno H; Yamano T; Kiyono T; Konishi A; Inoue T
    Nihon Shokakibyo Gakkai Zasshi; 1995 Aug; 92(8):1200-5. PubMed ID: 7563929
    [No Abstract]   [Full Text] [Related]  

  • 11. Containing hepatitis C.
    Maddrey WC
    Hosp Pract (1995); 1997 Mar; 32(3):107-9, 113-4 passim; discussion 128. PubMed ID: 9078976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of daily administration period of natural alpha-interferon in patients with chronic hepatitis C.
    Toyoda H; Nakano S; Kumada T; Takeda I; Sugiyama K; Osada T; Kiriyama S
    Am J Gastroenterol; 1996 Apr; 91(4):743-7. PubMed ID: 8677941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Disappointing response of chronic C hepatitis to interferon].
    Theodor E; Regev A
    Harefuah; 1997 Mar; 132(6):402-3, 447. PubMed ID: 9153855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of acute hepatitis C].
    Yokosuka O; Mikata R
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):357-60. PubMed ID: 15359821
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatitis B and C: current therapy].
    Bruch HR; Höhner U; Müller R
    Praxis (Bern 1994); 1998 Oct; 87(42):1408-12. PubMed ID: 9824948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maxim and Roche collaborate for development of hepatitis C drug.
    AIDS Read; 2000 Sep; 10(9):545. PubMed ID: 11019452
    [No Abstract]   [Full Text] [Related]  

  • 17. Dual hepatitis B virus and hepatitis C virus infection: To treat or not to treat, and how?
    Husa P
    J Gastroenterol Hepatol; 2005 May; 20(5):669-70. PubMed ID: 15853976
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of sustained efficacy of interferon in patients with chronic hepatitis C.
    Vento S; Concia E; Ferraro T
    N Engl J Med; 1996 May; 334(22):1479-80. PubMed ID: 8618600
    [No Abstract]   [Full Text] [Related]  

  • 19. [Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives].
    Marcellin P; Pouteau M; Martinot M; Boyer N; Castelnau C; Benhamou JP; Erlinger S
    Gastroenterol Clin Biol; 1995 Dec; 19(12):991-1000. PubMed ID: 8729410
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recombinant alpha 2b interferon in the treatment of chronic viral hepatitis C: comparison of 2 schemes, classical and high-dosage].
    Polus M
    Rev Med Liege; 1995 May; 50(5):226-9. PubMed ID: 7784752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.